Prosecution Insights
Prosecution Insights
4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (25%) |
| Double-patenting + other | 2 (50%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STOICA, ELLY GERALD | 2 | 66.7% | +22.8% |
| CANELLA, KAREN A | 1 | 62.2% | +32.8% |
| BRISTOL, LYNN ANNE | 1 | 63.5% | +39.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18323722 | MASKED ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND METHOD | STOICA, ELLY GERALD | 77d |
| 18400894 | MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF | STOICA, ELLY GERALD | — |
| 18354353 | ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHODS OF USE THEREOF | CANELLA, KAREN A | — |
| 17230240 | MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAME | BRISTOL, LYNN ANNE | — |
| Art Unit | Apps |
|---|---|
| 1647 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18400894 | MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF | STOICA, ELLY GERALD | — | §112DP | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18354353 | ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHODS OF USE THEREOF | CANELLA, KAREN A | — | §112DP | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18323722 | MASKED ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND METHOD | STOICA, ELLY GERALD | 1647 | §112 | Non-Final OA | 77d | Pending | May 25, 2023 |
| 17230240 | MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAME | BRISTOL, LYNN ANNE | 1643 | Other | Final Rejection | — | Pending | Apr 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial